Furthermore, the protein levels of SMAD and TGFβR1 in NSCLC cells were reduced by ELK4 knockdown, confirming that MSI2 relieved this inhibitory effect (Figure 5E). This evidence concerns the gene ELK4 and non-small cell lung carcinoma.